Antimetabolite Immunosuppressant

This page covers all Antimetabolite Immunosuppressant drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Inosine-5'-monophosphate dehydrogenase 2.

Targets

Inosine-5'-monophosphate dehydrogenase 2

Marketed (2)

• Mycophenolate · Novartis · Immunology
• Cellcept · Roche Palo · Oncology
  Cellcept works by inhibiting the enzyme inosine-5'-monophosphate dehydrogenase 2, which is necessary for the production of guanosine nucleotides.